04:30 PM EDT, 08/10/2026 (MT Newswires) -- Alamar Biosciences ( ALMR ) late Monday reported a Q2 net loss of $0.22 per diluted share, narrowing from a loss of $0.62 a year earlier.

Analysts polled by FactSet expected a loss of $0.31.

Revenue for the three months ended June 30 was $29.4 million, up from $16.2 million a year earlier.

Analysts expected $25.9 million.

For the full-year 2026, the company expects revenue of $116 million to $120 million. Analysts expected $113.2 million.